Preliminary 2022 MY Statewide Clinical Quality Measure Results for Medical Group Review until April 21st

This is your official opportunity to review and comment on the preliminary clinical quality performance measure results for your medical group. This email includes information on the data review, comment, and appeal process, and expected public reporting timeline.

2022 dates of service are reflected in these results unless otherwise noted.

Measures and Reporting
Measures included in this review are the following:

1. Adolescent Mental Health and/or Depression Screening

2. Colorectal Cancer Screening

3. Optimal Asthma Control & Education and Self-Management - Adult

4. Optimal Asthma Control & Education and Self-Management - Child

5. Optimal Diabetes Care

6. Optimal Vascular Care

7. Depression Care, Process and Outcome Measures – Adult*

8. Depression Care, Process and Outcome Measures – Adolescent*

*PHQ-9 Utilization measurement period 09/01/2022-12/31/2022

Outcome measure index period 11/01/2020-10/31/2021 with accompanying six- and 12-month follow-up assessments through 12/31/2022

Depression Care measures will be reviewed later. Please watch for a separate communication soon. Measures are reported at the clinic and medical group levels. They are calculated from data abstracted and submitted by clinics and are independently validated by MNCM. Measures that are part of the Statewide Quality Reporting and Measurement System slate are included in this review. MNCM publicly reports final results with the exception of the Asthma Education and Self-Management measures.

Please note that the results in the data files are preliminary and are not final until all data validation, including this review period, are complete. Also, please note that the review files and results are considered confidential.

If you notice that a clinic is unlisted, the clinic had less than 30 patients reported, or the measure was not applicable to that practice. To be publicly reported, a clinic must meet data reliability standards by having at least 30 eligible patients. This review includes results of clinics and medical groups that will be publicly reported. Data from all clinics – both publicly reported and not – are included in the rolled up medical group and statewide rates.

Performance ratings (e.g., Top, Above Average, Average, Below Average) are not included in this review but will be available for preview prior to public reporting of final risk adjusted results.